- Home
- EMCG vs SHLT Comparison
EMCG vs SHLT Comparison
Compare EMCG & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMCG
- SHLT
- Stock Information
- Founded
- EMCG 2021
- SHLT 1987
- Country
- EMCG United States
- SHLT Israel
- Employees
- EMCG N/A
- SHLT N/A
- Industry
- EMCG
- SHLT Business Services
- Sector
- EMCG
- SHLT Consumer Discretionary
- Exchange
- EMCG NYSE
- SHLT Nasdaq
- Market Cap
- EMCG 52.4M
- SHLT 49.7M
- IPO Year
- EMCG 2022
- SHLT N/A
- Fundamental
- Price
- EMCG $11.68
- SHLT $2.87
- Analyst Decision
- EMCG
- SHLT Strong Buy
- Analyst Count
- EMCG 0
- SHLT 1
- Target Price
- EMCG N/A
- SHLT $11.00
- AVG Volume (30 Days)
- EMCG 2.6K
- SHLT 58.3K
- Earning Date
- EMCG 01-01-0001
- SHLT 09-26-2024
- Dividend Yield
- EMCG N/A
- SHLT N/A
- EPS Growth
- EMCG N/A
- SHLT N/A
- EPS
- EMCG 0.23
- SHLT N/A
- Revenue
- EMCG N/A
- SHLT $55,939,000.00
- Revenue This Year
- EMCG N/A
- SHLT N/A
- Revenue Next Year
- EMCG N/A
- SHLT N/A
- P/E Ratio
- EMCG $49.99
- SHLT N/A
- Revenue Growth
- EMCG N/A
- SHLT N/A
- 52 Week Low
- EMCG $10.96
- SHLT $2.54
- 52 Week High
- EMCG $13.39
- SHLT $8.58
- Technical
- Relative Strength Index (RSI)
- EMCG 59.70
- SHLT 48.65
- Support Level
- EMCG $11.63
- SHLT $2.65
- Resistance Level
- EMCG $11.74
- SHLT $2.92
- Average True Range (ATR)
- EMCG 0.02
- SHLT 0.28
- MACD
- EMCG 0.00
- SHLT -0.03
- Stochastic Oscillator
- EMCG 33.33
- SHLT 23.66
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.